Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Adicionar filtros








Intervalo de ano
1.
Braz. arch. biol. technol ; 62: e19180556, 2019. tab, graf
Artigo em Inglês | LILACS | ID: biblio-1019540

RESUMO

Abstract The objective of this work was to screen sweet cassava accessions collected in smallholding areas in the Midwestern, Southeastern and Southern regions of Brazil, using 15 SSR molecular markers, to determine population structure and genetic diversity. Polymorphism was detected in every loci analyzed, with mean of 6.33 alleles per locus, and mean polymorphism information content (PIC) of 0.6057, pointing out that the primers were highly informative. The observed heterozygosity ranged from 0.0709 (SSRY 101) to 0.9398 (GA 12), with a mean of 0.6511, and mean genetic diversity of 0.6578, ranging from 0.3592 (GA 136) to 0.8116 (SSRY 21). The most dissimilar combinations observed were BGM526PR-BGM596MS, BGM526PR-BGM622MS and BGM526PR-BGM629MS. The traditional cassava cultivars assessed were divided into four distinct groups: two with cultivars from the South, one from the Southeast and one from the Midwestern region of Brazil. The variances among and within groups determined by the analysis of molecular variance were 44 and 56%, respectively. The PhiPT parameter (analogue to Fst) of 0.44 indicates high differentiation among groups. Broad genetic diversity was found among the traditional sweet cassava cultivars assessed, and the most divergent groups were formed by cultivars from the South and the Midwestern regions of Brazil.


Assuntos
Manihot/genética , Banco de Sementes , Alelos , Hibridização Genética
2.
Rev. méd. Chile ; 144(7): 931-936, jul. 2016. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-794007

RESUMO

We report a 41-year-old man with HIV and a chronic obstructive pulmonary disease, treated for seven months with Fluticasone/Salmeterol and antiretroviral therapy (Lamivudine, Tenofovir, Atazanavir and Ritonavir). While using these medications, the patients developed a Cushing syndrome in a period of five months. After performing laboratory and imaging tests, it was concluded that the most probable cause of the syndrome was the interaction of inhaled steroids with Ritonavir. After discontinuing these medications the syndrome reverted in a period of 8 months.


Assuntos
Humanos , Masculino , Adulto , Broncodilatadores/efeitos adversos , Infecções por HIV/tratamento farmacológico , Inibidores da Protease de HIV/efeitos adversos , Síndrome de Cushing/induzido quimicamente , Xinafoato de Salmeterol/efeitos adversos , Fluticasona/efeitos adversos , Nebulizadores e Vaporizadores , Broncodilatadores/uso terapêutico , Inibidores da Protease de HIV/uso terapêutico , Síndrome de Cushing/diagnóstico , Interações Medicamentosas , Xinafoato de Salmeterol/uso terapêutico , Fluticasona/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA